Table 1.
Antibiotic susceptibility pattern of the studied isolates
| Antibiotics | Non-susceptible isolates no. (%) | Non-susceptible E. coli isolates no.(%) | Non-susceptible K. pneumoniae isolates. no. (%) | P value (E. coli / K.pn.) |
|---|---|---|---|---|
| Piperacillin | 72 (99%) | 15 (94%) | 55 (100%) | 0.5080 |
| Cefotaxime | 68 (93%) | 13 (81%) | 53 (96%) | 0.1274 |
| Cefoxitin | 55 (75%) | 9 (56%) | 44 (80%) | 0.1160 |
| Aztreonam | 65 (89%) | 13 (81%) | 50 (91%) | 0.5311 |
| Meropenem | 36 (49%) | 6 (38%) | 29 (53%) | 0.4306 |
| Ciprofloxacin | 66 (90%) | 12 (75%) | 52 (95%) | 0.0670 |
| Ofloxacin | 58 (79%) | 12 (75%) | 46 (84%) | 0.6753 |
| Amikacin | 55 (75%) | 9 (56%) | 45 (82%) | 0.0756 |
| Gentamicin | 65 (89%) | 11 (69%) | 52 (95%) | 0.0154 |
| Sulfomethoxazole / trimethoprim | 62 (85%) | 11 (69%) | 49 (89%) | 0.1126 |
| Tigecycline | 16 (22%) | 1 (6%) | 15 (27%) | 0.1523 |
Statistically significant P values are underlined